Device Technologies has unveiled the Ziemer femto LDV Z8 laser in New Zealand, describing it as a true “Swiss Army knife” for eye surgery. The Swiss-made laser’s capabilities not only span refractiv
Glaucoma New Zealand (GNZ) has appointed Shubhneet Nanda as clinical educator to manage its newly launched Sightwise patient education and support programme.
The ZEISS Cirrus 6000 OCT device, integrating high-speed imaging and an artificial intelligence (AI)-guided OCT image assessment support tool, received TGA approval just over a month ago, said Lahiru Gunasena, Zeiss product specialist.
Researchers in India found using swept-source anterior-segment optical coherence tomography (SS-ASOCT) to analyse the trabecular meshwork (TM) helped identify early-onset childhood glaucoma. For the
Writing in Advances in Therapy, researchers found astaxanthin supplementation reduced chronic and acute digital eye strain (DES), while enhancing objective measures of visual performance in school-age
Seeking to clarify foundational terminology used in clinical, research and regulatory settings, the International Myopia Institute (IMI) has released a new editorial, ‘Myopia Correction, Myopia Contro
A longitudinal population-based cohort study found long-term variability in blood pressure may be associated with an increased risk of advanced age-related macular degeneration (AMD), particularly for
According to research from Massey University, the risk of burnout is twice as high for medical doctors compared with other workforce groups in Aotearoa. Though the Medscape Physician Burnout & Depre
WSPOS promotes repeated low-level red-light therapy in its latest Myopia Consensus Statement
With a shortage of ophthalmologists in the regions, RANZCO’s education committee surveyed 23 New Zealand-based ophthalmology trainees and a few recently made fellows to understand what mattered to them after they completed their training. Presenting the results at the RANZCO NZ 2025 conference in Ro
A rare and grisly case of the autoimmune condition pyoderma gangrenosum (PG) was documented by Nelson Hospital’s Drs Garry Singh and Sacha Moore, and presented as a poster at the RANZCO NZ 2025.
iScribe, an artificial intelligence (AI) note-taking tool that converts patient conversations into clinical notes, referrer and patient letters, has gained 15-20% of the Australian ophthalmology market since its launch at the beginning of 2024, reported its parent company Akuru.
